IP Library Granted Patent US 7,538,220
Granted Patent B2
US 7,538,220 · App. 11/805,169 · Granted May 26, 2009

Intermediates in the preparation of homocamptothecin analogs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,538,220
App. No.
11/805,169
Granted
May 26, 2009
Kind
B2
Abstract

A compound having the formula in racemic form, enantiomerically enriched form or enantiomerically pure form; wherein X is a radical precursor; R 5 is a C 1-10 alkyl group, an alkenyl group, an alkynyl group, or a benzyl group; R 6 is an alkyl group, —Si(R 8 R 9 R 10 ) or —(R 7 )Si(R 8 R 9 R 10 ), wherein R 7 is an alkylene group, an alkenylene group, or an alkynylene group; and R 8 , R 9 and R 10 are independently a C 1-10 alkyl group, a C 2-10 alkenyl group, a C 2-10 alkynyl group, an aryl group or a —(CH 2 ) N R 11 group, wherein N is an integer within the range of 1 through 10 and R 11 is a hydroxy group, an alkoxy group, an amino group, an alkylamino group, a dialkylamino group, a halogen atom, a cyano group, —SR c or a nitro group; and R 13 is H, F or —CH 3 .

Claims (10)

1. A compound having the formula

in racemic form, enantiomerically enriched form or enantiomerically pure form;

wherein X is a radical precursor;

R 5 is a C 1-10 alkyl group, an alkenyl group, an alkynyl group, or a benzyl group;

R 6 is an alkyl group, —Si(R 8 R 9 R 10 ) or —(R 7 )Si(R 8 R 9 R 10 ), wherein R 7 is an alkylene group, an alkenylene group, or an alkynylene group; and R 8 , R 9 and R 10 are independently a C 1-10 alkyl group, a C 2-10 alkenyl group, a C 2-10 alkynyl group, an aryl group or a —(CH 2 ) N R 11 group, wherein N is an integer within the range of 1 through 10 and R 11 is a hydroxy group, an alkoxy group, an amino group, an alkylamino group, a dialkylamino group, a halogen atom, a cyano group, —SR c or a nitro group; and

R 13 is H, F or —CH 3 .

2. The compound of claim 1 wherein R 5 is an ethyl group, an allyl group, a benzyl group or a propargyl group.

3. The compound of claim 1 wherein X is Br or I.

4. The compound of claim 3 wherein R 13 is H.

5. The compound of claim 4 wherein R 5 is an ethyl group.

Assignments (3)
CONFIRMATORY LICENSE Recorded Oct 21, 2009
From: UNIVERSITY OF PITTSBURGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023404/0598 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2007
From: BURKE, THOMAS G.
To: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
Reel/Frame 019890/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2007
From: CURRAN, DENNIS P.; BOM, DAVID
To: UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 019901/0291 →